|
Recent Newsletters
Focus on hypertrophic cardiomyopathy: ASE HCM Forum coverage |
Imaging's role in the treatment of HCM | FDA approves new cryoablation system for AFib | Fasting before TAVR |
DRAFT 1 - Focus on hypertrophic cardiomyopathy: ASE HCM Forum coverage |
Weight loss drug reduces CV risks | HCM may be widely underdiagnosed | TAVR controversy leads to lawsuit |
News Alert: Weight loss drug semaglutide reduces risk of adverse cardiovascular events |
TAVR Highlights: A key recall after 26 injuries | New valve makes its debut | Permanent pacemakers | Much more |
Colchicine before PCI | NFL player's AFib diagnosis | Cardiologist remembered as a ‘true legend’ |